Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Wants Assessment Of New Drug Review ‘Culture’ Amid Modernization, Other Changes
Dec 03 2021
•
By
Derrick Gingery
After the assessment, each team surveyed will receive a report with their experienced and desired organizational culture. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership